Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • BIOBUSINESS BRIEFS

2020 biotech IPOs shatter all the records

  1. Tess Cameron

    1. RA Capital Management, Boston, MA, USA.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  2. Chris Morrison

    1. RA Capital Management, Boston, MA, USA.

    View author publications

    You can also search for this author in PubMed  Google Scholar

Despite the COVID-19 pandemic, or in some cases because of it, public investor capital has flooded into biotech companies entering the global public markets. In 2020, the sector recorded just over 100 initial public offerings (IPOs), nearly double the number in 2019. These biotech companies — working on drug discovery and development programmes, but excluding diagnostic, medical device and life science tool firms — raised more than US$20 billion in total proceeds, a record haul that surpasses 2018’s and 2019’s already impressive totals combined.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

Nature Reviews Drug Discovery 20, 93-94 (2021)

doi: https://doi.org/10.1038/d41573-021-00019-5

Competing Interests

RA Capital is a registered investment adviser. This article is not intended, and should not be construed as, investment advice or recommendation to invest in any security. Likewise, this article is not intended as a solicitation to invest in any RA Capital product or service. RA Capital may hold long and/or short positions in companies referenced. All companies mentioned were chosen based on their IPOs’ gross proceeds in the subgroups described.

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links